Are SSRIs a cost-effective alternative to tricyclics?

British Journal of Psychiatry

Volumn 168, Issue APR., 1996, Pages 404-409

  Hotopf, Matthew ^a,c   Lewis, Glyn ^b   Normand, Charles ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; DOSULEPIN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DRUG CONTRAINDICATION; DRUG COST; DRUG EFFICACY; HUMAN; META ANALYSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SUICIDE; TREATMENT FAILURE;

EID: 0029943581     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.168.4.404     Document Type: Article

References (34)

1. ALVAREZ, F. & DEL RIO, M. (1994) Drugs and driving. Lancet, 344, 282.
2. ANDERSON, I. M. & TOMENSON, B. M. (1995) Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. British Medical Journal, 310, 1433-1438.
3. ASHFORD, J. J. (1994) Total profile of drug should be considered. British Medical Journal, 309, 1083.
4. BEUZEN, J. N., RAVILY, V. F., SOUETRE, E. J., et al (1993) Impact of fluoxetine on work loss in depression. International Journal of Psychopharmacology, 8, 319-321.
5. BLACKER, C. V. R. & CLARE, A. W. (1987) Depressive disorder in primary care. British Journal of Psychiatry, 150, 737-751.
6. BOYER, W. F. & FEIGHNER, J. P. (1993) The financial implications of starting treatment with a selective serotonin reuptake inhibitor or tricyclic antidepressant in drug-naïve depressed patients. In Health Economics of Depression (eds B. Jönsson & J. Rosenbaum), pp. 65-75. London: Wiley.
7. BRATFOS, O. & HAUG, J. O. (1968) The course of manic-depressive psychosis: a follow-up investigation of 215 patients. Acta Psychiatrica Scandinavica, 44, 89-112.
8. CARR-HILL, R. A. (1991) Current practice in obtaining the "Q" in QALYs: a cautionary note. British Medical Journal, 305, 699-701.
9. CROFT-JEFFREYS, C. & WILKINSON, G. (1989) Estimated costs of neurotic disorder in UK general practice 1985. Psychological Medicine, 19, 549-558.
10. DONOVAN, S., MCGRADY, H., POWNALL, R., et al (1993) The efficacy and tolerability of dothiepin and three selective serotonin reuptake inhibitors in the treatment of major depression: a review of six double blind studies. Current Therapeutic Research, 54, 275-289.
11. DRUGS AND THERAPEUTIC BULLETIN (ANON) (1993) Selective serotonin reuptake inhibitors for depression. Drugs and Therapeutic Bulletin, 31, 57-58.
12. DRUMMOND, M. F., STODDARD, G. L. & TORRANCE, G. W. (1987) Methods for the Economic Evaluation of Health Care. Oxford: Oxford University Press.
13. EDWARDS, G. (1995) Suicide and antidepressants. British Medical Journal, 310, 205-206.
14. EFFECTIVE HEALTH CARE (1993) The treatment of depression in primary care. Effective Health Care Bulletin, 5, 1-12.
15. FREEMANTLE, N., HOUSE, A., SONG, F., et al (1994) Prescribing selective serotonin reuptake inhibitors as a strategy for prevention of suicide. British Medical Journal, 309, 249-253.
16. _ & MAYNARD, A. (1994) Something rotten in the state of clinical and economic evaluations. Health Economics, 3, 63-67.
17. GOLDACRE, M., SEAGROATT, V. & HAWTON, K. (1993) Suicide after discharge from psychiatric in-patient care. Lancet, 342, 283-286.
18. HAMILTON, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56-62.
19. HENRY, J. A. & MARTIN, A. J. (1987) The risk-benefit assessment of antidepressant drugs. Medical Toxicology, 21, 445-462.
20. JONSSON, B. (1994) Economic evaluation and clinical uncertainty: response to Freemantle and Maynard. Health Economics, 3, 305-307.
21. _ & BEBBINGTON, P. E. (1994) What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment. British Journal of Psychiatry, 164, 665-673.
22. KIND, P. & SORENSEN, J. (1993) The costs of depression. International Journal of Psychopharmacology, 7, 191-195.
23. LE PEN, C., LEVY, E., RAVILY, V., et al (1994) The cost of treatment dropout in depression. A cost benefit analysis of fluoxetine vs tricyclics. Journal of Affective Disorders, 31, 1-18.
24. MONTGOMERY, S. A., HENRY, J., MCDONALD, G., et al (1994) Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates. International Clinical Psychopharmacology, 9, 47-53.
25. _ & KASPER, S. (1995) Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. International Clinical Psychopharmacology, 9 (suppl 4), 33-40.
26. OFFICE OF POPULATION CENSUSES AND SURVEYS (1990) Mortality Statistics. London: HMSO.
27. PANDE, A. C. & SAYLER, M. E. (1993) Adverse events and treatment discontinuations in fluoxetine clinical trials. International Clinical Psychopharmacology, 8, 267-269.
28. PAYKEL, E. S. (1989) The background: extent and nature of the disorder. In Depression: an Integrative Approach (eds K. Herbst & E. S. Paykel), pp. 3-17. Oxford: Heinemann.
29. _ & PRIEST, R. G. (1992) Recognition and management of depression in general practice: consensus statement. British Medical Journal, 305, 1198-1202.
30. PERRIS, C. & D'ELIA, G. (1966) A study of bipolar and unipolar depressive psychoses: mortality, suicide and life cycles. Acta Psychiatrica Scandinavica, 194 (suppl), 172-183.
31. SONG, F., FREEMANTLE, N., SHELDON, T. A., et al (1993) Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. British Medical Journal, 306, 683-687.
32. TUBMAN, T. R. J., HALLIDAY, H. L. & NORMAND, C. (1990) Cost of surfactant treatment for severe neonatal respiratory distress syndrome: a randomised controlled trial. British Medical Journal, 301, 842-845.
33. VAN HOWVELINGEN, H. C. & ZWINDERMAN, K. H. (1993) A bivariate approach to meta-analysis. Statistics in Medicine, 12, 2273-2284.
34. WELLS, K. B., STEWART, A., HAYS, R. D., et al (1989) The functioning and wellbeing of depressed patients: results from the medical outcomes study. Journal of the American Medical Association, 262, 914-919.